David C.W. Lau

14.7k total citations · 6 hit papers
98 papers, 6.7k citations indexed

About

David C.W. Lau is a scholar working on Endocrinology, Diabetes and Metabolism, Pharmacology and Physiology. According to data from OpenAlex, David C.W. Lau has authored 98 papers receiving a total of 6.7k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Endocrinology, Diabetes and Metabolism, 39 papers in Pharmacology and 34 papers in Physiology. Recurrent topics in David C.W. Lau's work include Pharmacology and Obesity Treatment (38 papers), Diabetes Treatment and Management (33 papers) and Diet and metabolism studies (21 papers). David C.W. Lau is often cited by papers focused on Pharmacology and Obesity Treatment (38 papers), Diabetes Treatment and Management (33 papers) and Diet and metabolism studies (21 papers). David C.W. Lau collaborates with scholars based in Canada, United States and United Kingdom. David C.W. Lau's co-authors include Raj Padwal, John Wilding, Carel W. le Roux, Ken Fujioka, Cíntia Chaves Curioni, Frank L. Greenway, Diana Rucker, Arne Astrup, Christine B. Jensen and Rafael Violante Ortíz and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Journal of Clinical Investigation.

In The Last Decade

David C.W. Lau

95 papers receiving 6.4k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management

2015 1.8k citations Ken Fujioka, Frank L. Greenway et al. profile →
2006 Canadian clinical practice guidelines on the management and prevention of obesity in adults and children [summary]

2007 861 citations David C.W. Lau, Arya M. Sharma et al. Canadian Medical Association Journal profile →
Long term pharmacotherapy for obesity and overweight: updated meta-analysis

2007 583 citations David C.W. Lau et al. profile →
Safety, tolerability, pharmacokinetics, and pharmacodynamics of concomitant administration of multiple doses of cagrilintide with semaglutide 2·4 mg for weight management: a randomised, controlled, phase 1b trial

2021 215 citations Domenica Rubino, Altynai Satylganova et al. The Lancet profile →
Once-weekly cagrilintide for weight management in people with overweight and obesity: a multicentre, randomised, double-blind, placebo-controlled and active-controlled, dose-finding phase 2 trial

2021 162 citations David C.W. Lau, Lars Erichsen et al. The Lancet profile →
Efficacy and safety of once-weekly semaglutide 2·4 mg versus placebo in people with obesity and prediabetes (STEP 10): a randomised, double-blind, placebo-controlled, multicentre phase 3 trial

2024 73 citations Barbara McGowan, Sue D. Pedersen et al. The Lancet Diabetes & Endocrinology profile →

Peers

David C.W. Lau

EDM

PHARM

PHYSI

SURGE

Hermann Toplak Austria

Alfredo Halpern Brazil

Sean Wharton Canada

Nick Finer United Kingdom

Christopher D. Still United States

Peter Kopelman United Kingdom

Leigh Perreault United States

W. Timothy Garvey United States

V. Martikkala Finland

Osama Hamdy United States

Hermann Toplak Austria

David C.W. Lau

1.7k ×0.6

EDM

1.2k ×0.5

PHARM

3.0k ×1.3

PHYSI

1.7k ×1.5

SURGE

897 ×0.9

Citations per year, relative to David C.W. Lau David C.W. Lau (= 1×) peers Hermann Toplak

Countries citing papers authored by David C.W. Lau

Since Specialization

Citations

This map shows the geographic impact of David C.W. Lau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David C.W. Lau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David C.W. Lau more than expected).

Fields of papers citing papers by David C.W. Lau

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David C.W. Lau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David C.W. Lau. The network helps show where David C.W. Lau may publish in the future.

Co-authorship network of co-authors of David C.W. Lau

This figure shows the co-authorship network connecting the top 25 collaborators of David C.W. Lau. A scholar is included among the top collaborators of David C.W. Lau based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David C.W. Lau. David C.W. Lau is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lau, David C.W., et al.. (2025). Mini Review: Highlight of Recent Advances and Applications of MALDI Mass Spectrometry Imaging in 2024. PubMed. 6(1). e70016–e70016. 2 indexed citations

Larsen, Sára, et al.. (2024). Cost-effectiveness of weight-management pharmacotherapies in Canada: a societal perspective. International Journal of Obesity. 48(5). 683–693. 10 indexed citations

Lau, David C.W., et al.. (2024). Therapeutic inertia in obesity management among people living with obesity from the perspective of general/family practitioners in Canada: A mixed‐methods study. Clinical Obesity. 15(1). e12701–e12701. 1 indexed citations

Lau, David C.W., Lars Erichsen, Ann Marie Ocampo Francisco, et al.. (2021). Once-weekly cagrilintide for weight management in people with overweight and obesity: a multicentre, randomised, double-blind, placebo-controlled and active-controlled, dose-finding phase 2 trial. The Lancet. 398(10317). 2160–2172. 162 indexed citations breakdown →

Proietto, Joseph, David C.W. Lau, Ken Fujioka, et al.. (2019). Early weight loss responders to liraglutide 3.0 mg had greater weight loss, regression to normoglycaemia, and reduced T2D development at 3 years vs early non-responders: SCALE Obesity and Prediabetes. Obesity Research & Clinical Practice. 13(1). 55–56. 1 indexed citations

Hamel, Candyce, Adrienne Stevens, Kavita Singh, et al.. (2014). Do sugar-sweetened beverages cause adverse health outcomes in adults? A systematic review protocol. Systematic Reviews. 3(1). 108–108. 18 indexed citations

Grover, Steven A., Mohammed Kaouache, Lawrence Joseph, et al.. (2014). Years of life lost and healthy life-years lost from diabetes and cardiovascular disease in overweight and obese people: a modelling study. The Lancet Diabetes & Endocrinology. 3(2). 114–122. 135 indexed citations

Teoh, Hwee, Jean‐Pierre Després, Robert Dufour, et al.. (2013). Identification and Management of Patients at Elevated Cardiometabolic Risk in Canadian Primary Care: How Well Are We Doing?. Canadian Journal of Cardiology. 29(8). 960–968. 14 indexed citations

Friedenreich, Christine M., David C.W. Lau, Kerry S. Courneya, et al.. (2012). Case–control study of markers of insulin resistance and endometrial cancer risk. Endocrine Related Cancer. 19(6). 785–792. 38 indexed citations

10.

Lau, David C.W.. (2011). New Insights in the Prevention and Early Management of Type 2 Diabetes. Canadian Journal of Diabetes. 35(3). 239–241. 6 indexed citations

11.

Lau, David C.W.. (2011). Is Surgery an Option in the Treatment of Type 2 Diabetes?. Canadian Journal of Diabetes. 35(2). 85–86. 2 indexed citations

12.

Lau, David C.W.. (2011). A World with Fewer People with Diabetes Noncommunicable Diseases. Canadian Journal of Diabetes. 35(4). 314–316.

13.

Southern, Danielle A., Alun Edwards, Stafford Dean, et al.. (2010). Validity of Administrative Data Claim-based Methods for Identifying Individuals with Diabetes at a Population Level. Canadian Journal of Public Health. 101(1). 61–64. 36 indexed citations

14.

Lau, David C.W.. (2010). The Cost of Diabetes: A Game Changer. Canadian Journal of Diabetes. 34(1). 16–18. 3 indexed citations

15.

Lau, David C.W.. (2010). Excess Prevalence Mortality Rates of Diabetes Cardiovascular Disease Among South Asians: A Call to Action. Canadian Journal of Diabetes. 34(2). 102–104. 3 indexed citations

16.

Lau, David C.W.. (2009). Fighting Diabetes — The Tsunami of Noncommunicable Diseases. Canadian Journal of Diabetes. 33(4). 348–349. 5 indexed citations

17.

Lau, David C.W.. (2007). Evidence-based Canadian Obesity Clinical Practice Guidelines: Relevance to Diabetes Management. Canadian Journal of Diabetes. 31(2). 148–152. 3 indexed citations

18.

Fisberg, Mauro, Louise A. Baur, Walter Chen, et al.. (2004). Obesity in Children and Adolescents: Working Group Report of the Second World Congress of Pediatric Gastroenterology, Hepatology, and Nutrition. Journal of Pediatric Gastroenterology and Nutrition. 39(S2). 5 indexed citations

19.

Wolever, Thomas M.S., Tapan K. Basu, Jean‐Louis Chiasson, et al.. (2000). Miglitol, an α-glucosidase inhibitor, prevents the metformin-induced fall in serum folate and vitamin B12 in subjects with type 2 diabetes. Nutrition Research. 20(10). 1447–1456. 17 indexed citations

20.

Meltzer, S. J., Lawrence A. Leiter, Denis Daneman, et al.. (1998). 1998 clinical practice guidelines for the management of diabetes in Canada. Canadian Medical Association Journal. 159(8). 1–29. 307 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact